Monalizumab
1 paper1 finding
- 1 lab in 1 country
- Funder: National Institutes of Health
- Humans1
Outcomes
1Lysis of senescent fibroblasts
upin human cells1
1 study
Lysis of senescent fibroblasts
upin human cells1
Monalizumab increases lysis of senescent fibroblasts in human cells.
“Monalizumab, a clinical-grade NKG2A inhibitor, reactivated patient-derived NK cells and enhanced lysis of human senescent fibroblasts in vitro.”
Cellsin vitroclinical-gradepatient-derived NK cells and human senescent fibroblasts
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts
Science translational medicine13 May 2026
Latest
1 in 12 monthsScience Translational Medicine
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts
Study in peopleIdiopathic pulmonary fibrosis